General
Unless stated otherwise, all used solvents were anhydrous. TLC was performed on silica gel pre-coated aluminium plates Silica gel/TLC-cards, UV 254 (Fluka), and compounds were detected by UV light (254 nm), by heating (detection of dimethoxytrityl group; orange color), by spraying with 1% solution of ninhydrine to visualize amines, and by spraying with 1% solution of 4-(4-nitrobenzyl)pyridine in ethanol followed by heating and treating with gaseous ammonia (blue color of mono-and diesters of phosphonic acid). Preparative column chromatography was carried out on silica gel (40-60µm; Fluka), and elution was performed at the flow rate of 40 ml/min. The following solvent systems were used for TLC and preparative chromatography: toluene-ethyl acetate 1:1 (T); chloroform-ethanol 9:1 (C1); ethyl acetate-acetone-ethanol-water 6:1:1:0.5 (H3); ethyl acetate-acetone-ethanol-water 4:1:1:1 (H1). The concentrations of solvent systems are stated in volume percents (%, v/v) . Purity of prepared compounds was determined by LC-MS performed on Waters AutoPurification System with 2545 Quarternary Gradient Module and 3100 Single Quadrupole Mass Detector using LUNA C18, column (Phenomenex, 100 x 4.6 mm, 3 µm) at flow rate 1 ml/min. Typical conditions: mobile phase, A -50mM NH4HCO3; B -50 mM NH4HCO3 in 50% aq. CH3CN; C -CH3CN; A→B/10 min, B→C/10 min, C/5 min. Preparative RP HPLC was performed on LC5000 Liquid Chromatograph (INGOS-PIKRON, CR) using Luna C18 (2) column (250 x 21.2 mm, 5 µm) at flow rate of 10 ml/min by a gradient elution of methanol in 0.1M TEAB pH 7.5 (A = 0.1M TEAB; B = 0.1M TEAB in 50% aq. methanol; C = methanol) or without buffer. 
Synthesis of DR5557
TBDMSCl (6.37 g, 42.27 mmol) was added to solution of 2',3'-isopropylideneuridine (1) (8.01 g, 28.18 mmol) in pyridine. The reaction mixture was stirred at rt overnight. Solvent was removed in vacuo and product 2 was obtained by chromatography on silica gel using linear gradient of ethyl acetate in toluene in 95% yield (10.7 g, 26.8 mmol). 2 was without further characterization dissolved in DCM (300 ml) and triethylamine (9 ml, 65 mmol), DMAP (0.2 g, 1.6 mmol) and mesitylenesulfonylchloride (14 g, 65 mmol) were added. The reaction mixture was stirred at rt for 3 h and washed with saturated solution of NaHCO3. Organic phase was dried over Na2SO4, evaporated and intermediate 3 was obtained by chromatography on silica gel using linear gradient of ethyl acetate in toluene in 50% yield (7.8 g, 13.4 mmol). Intermediate 3 (2.78 g, 4.79 mmol) was (without further characterization) treated with propargylamine (0.61 ml, 9.57 mmol) in DMF (50 ml) at 90 °C overnight. The reaction mixture was concentrated in vacuo and treated with TBAF (0.5 M in THF, 30 ml) for 4 h. Dowex 50 in triethylammonium form (20 g) was added, the suspension was stirred for another 10 min, filtered and concentrated in vacuo. Intermediate 5 was obtained by linear gradient of ethanol in chloroform in 85% yield (1.31g, 4.05 mmol). TPSCl (3.68 g, 12.15 mmol) was added to mixture of 5 (1.31 g, 4.05 mmol), hexadecyl vinylphosphonate (2.7 g, 8.1 mmol) and 1-methylimidazole (0.96 ml, 12.15 mmol) in DCM (80 ml). The reaction mixture was stirred at rt overnight, and washed with saturated solution of NaHCO3. The vinylphosphonate intermediate 6 was obtained by linear gradient of ethanol in chloroform. Mixture of vinylphosphonate 6 (0.32 g, 0.5 mmol) and [R,R]-3,4-dihydroxypyrrolidine (62 mg, 0.6 mmol) in nBuOH (5 ml) was stirred at 70 °C overnight. Solvent was removed in vacuo and the residue was treated with 0.5 M methanolic HCl (20 ml) overnight at rt. The reaction mixture was concentrated in vacuo and final DR5557 was obtained by the chromatography on silica gel using linear gradient of solvent system H1 (EtOAc:acetone:ethanol:water 4:1:1:1) in ethyl acetate in the form of white amorphous solid. 
Synthesis biotinylated LPPO DR5690
Azide-PEG3-Biotin Conjugate was purchased from Jena Bioscience (JB) and used according to JB recommendation for the reaction with DR5557. The final DR5690 was purified using preparative HPLC on reversed phase and its structure was proven by LC-MS. (dd, 4H, JH,P = 6.2, J5′,4′ = 3.3, H-5′); 4.42 (ddd, 2H, Jgem = 11.5, JH,P = 5.5, J5′a,4′ = 2.5, H-5′a); 5.92, 5.93 (2 × d, 2 × 1H, J1′,2′ = 4.2, H-1′); 6. 50, 6.51 (2 × dd, 2 × 1H, J4,3 = 3.3, J4,5 = 1.8, H-4-furyl); 6.97 -6.98 (m, 2H, H-3-furyl); 7.54 (dd, 2H, J5,4 = 1.8, J5,3 = 0.9, H-5-furyl); 8.03, 8 .04 (2 × s, 2 × 1H, H-6).
13
C NMR (125.7 MHz, DMSO-d6): 14.46 (CH3 (CH2)14CH2O) ; 24.26, 24.29 (2 × d, JC, P = 140.2, PCH2CH2N); 23.74, 26.55, 26.58, 30.23, 30.24, 30.48, 30.62, 30.63, 30.67, 30.69, 30.76, 30.77, 30.79, 30.80 (CH3(CH2) 
5-(furan-2-yl)-2´,3´-O-isopropyliden-uridine OS793 [2]
Bis(triphenylphosphine)palladium(II) dichloride (60 mg; 85 µmol; 5% mol) was added to the solution of 5-iodo-2´,3´-O-isopropylidene-uridine (0.7 g; 1.7 mmol) and 2-(tributylstannyl)furane (1.075 mL; 3.4 mmol) in DMF (10 mL) and reaction mixture was heated to 90 °C for 3 h. The reaction was then evaporated, dissolved in toluene and passed through Celite. Final OS793 was obtained by the chromatography on silica gel using linear gradient of ethyl acetate in toluene in the form of white amorphous solid (380 mg; 64 %). 
